{"version":"1.0","type":"link","title":"Clinical features, treatment, and outcomes of anti-PD-1/PD-L1 immune checkpoint inhibitors induced dermatomyositis.","author_name":"Xiao J 외","author_url":"https://prs-insight.online/author/Xiao%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94752","thumbnail_width":1200,"thumbnail_height":630}